340B performance depends on visibility across a complex network of EMRs, contract pharmacies, TPAs, manufacturers, wholesalers, and compliance workflows. Without that visibility, covered entities quietly forfeit revenue tied to claims that remain undiscovered.
Deep 340B expertise and purpose-built analytics, paired for one outcome: higher 340B revenue without compromising compliance or operational stability.
Selero doesn't sit on the sidelines. Our pharmacist-led team operates inside your program, reviewing claims, navigating manufacturer requirements, and surfacing opportunities a TPA was never built to find.
Eligibility, recovery, and pharmacy performance the moment claims post. Not in a monthly summary.
Surface high-value specialty prescriptions across every contract pharmacy relationship.
Reconcile disqualified prescriptions against EMR records, document eligibility, recover revenue.
Monthly outlook with manufacturer-level forecasting and program-health indicators.
Before Selero
~$40M
Annual 340B net revenue
TPA misconfiguration, partial pharmacy designations, no daily disqualification visibility, non-capture of prescriptions escaping the in-house pharmacy.
With Selero
~$50M
25% improvement in year one
Solutions implemented
Before Selero
~$20K
Net 340B contribution per month
TPA misconfiguration, partial pharmacy designations, no daily disqualification visibility.
With Selero
~$138K
Net 340B contribution per month
Solutions implemented